Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine whether the new centrally active analgesic and MS
Continus® are effective in the treatment of painful diabetic polyneuropathy.